Douglas J. Watson

4.1k total citations
79 papers, 3.1k citations indexed

About

Douglas J. Watson is a scholar working on Pharmacology, Surgery and Economics and Econometrics. According to data from OpenAlex, Douglas J. Watson has authored 79 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 15 papers in Surgery and 11 papers in Economics and Econometrics. Recurrent topics in Douglas J. Watson's work include Inflammatory mediators and NSAID effects (19 papers), Lipoproteins and Cardiovascular Health (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Douglas J. Watson is often cited by papers focused on Inflammatory mediators and NSAID effects (19 papers), Lipoproteins and Cardiovascular Health (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Douglas J. Watson collaborates with scholars based in United States, Canada and Germany. Douglas J. Watson's co-authors include Harry A. Guess, Thomas Rhodes, Bing Cai, Josephine M. Norquist, Antonio M. Gotto, Michael Clearfield, Elham Rahme, Deborah R. Shapiro, Hui Quan and James A. Bolognese and has published in prestigious journals such as Circulation, Gastroenterology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Douglas J. Watson

76 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas J. Watson United States	30	1.0k	893	515	468	466	79	3.1k
Stephen Dunn United States	32	484 0.5×	187 0.2×	596 1.2×	106 0.2×	380 0.8×	69	4.3k
Marc S. Williams United States	37	709 0.7×	185 0.2×	162 0.3×	143 0.3×	341 0.7×	227	7.1k
Kendrith M. Rowland United States	49	591 0.6×	137 0.2×	292 0.6×	98 0.2×	143 0.3×	188	8.5k
Per Lundborg Sweden	42	1.3k 1.2×	388 0.4×	182 0.4×	26 0.1×	538 1.2×	206	5.4k
Elizabeth Garrett United States	28	563 0.6×	190 0.2×	130 0.3×	296 0.6×	161 0.3×	82	3.4k
A. B. Atkinson United Kingdom	43	1.5k 1.5×	208 0.2×	3.5k 6.7×	49 0.1×	659 1.4×	172	8.3k
Peter van der Meer Netherlands	48	814 0.8×	122 0.1×	495 1.0×	358 0.8×	3.9k 8.4×	158	8.2k
Peter Jacobson United States	43	2.2k 2.2×	409 0.5×	977 1.9×	68 0.1×	795 1.7×	205	6.7k
Mary B. Daly United States	43	289 0.3×	209 0.2×	465 0.9×	56 0.1×	112 0.2×	175	10.9k
Stefan Winter Germany	37	469 0.5×	346 0.4×	279 0.5×	75 0.2×	759 1.6×	140	4.8k

Countries citing papers authored by Douglas J. Watson

Since Specialization

Citations

This map shows the geographic impact of Douglas J. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. Watson more than expected).

Fields of papers citing papers by Douglas J. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. Watson. The network helps show where Douglas J. Watson may publish in the future.

Co-authorship network of co-authors of Douglas J. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas J. Watson. A scholar is included among the top collaborators of Douglas J. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas J. Watson. Douglas J. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watson, Douglas J., Marc A. Riedl, Aleena Banerji, et al.. (2018). Use Of Central Venous Access Devices (CVAD) And Associated Outcomes In Hereditary Angioedema (HAE) Patients: Findings From A Large United States (US) Claims Database. Journal of Allergy and Clinical Immunology. 141(2). AB50–AB50. 1 indexed citations

Lumry, William R., Timothy Craig, Bruce L. Zuraw, et al.. (2018). Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 6(5). 1733–1741.e3. 67 indexed citations

Riedl, Marc A., Aleena Banerji, Michael Manning, et al.. (2017). Intravenous C1-INH [C1-INH(IV)] Use Among Patients with Hereditary Angioedema (HAE) in the United States (US) and Associated Health Care Resource Utilization (HCRU). Journal of Allergy and Clinical Immunology. 139(2). AB231–AB231.

Watson, Douglas J. & James H. Svara. (2010). More than Mayor or Manager: Campaigns to Change Form of Government in America's Large Cities. Georgetown University Press eBooks. 7 indexed citations

Kamal‐Bahl, Sachin, Douglas J. Watson, & Baishali Ambegaonkar. (2009). Patients’ experiences of niacin-induced flushing in clinical practice: A structured telephone interview. Clinical Therapeutics. 31(1). 130–140. 18 indexed citations

Cui, Yadong, Douglas J. Watson, Cynthia J. Girman, et al.. (2009). Effects of Increasing High-Density Lipoprotein Cholesterol and Decreasing Low-Density Lipoprotein Cholesterol on the Incidence of First Acute Coronary Events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). The American Journal of Cardiology. 104(6). 829–834. 48 indexed citations

Rahme, Elham, Alan Barkun, Hacene Nedjar, Sabine Gaugris, & Douglas J. Watson. (2008). Hospitalizations for Upper and Lower GI Events Associated With Traditional NSAIDs and Acetaminophen Among the Elderly in Quebec, Canada. The American Journal of Gastroenterology. 103(4). 872–882. 92 indexed citations

Avins, Andrew L., M. Michele Manos, Lynn Ackerson, et al.. (2008). Hepatic Effects of Lovastatin Exposure in Patients with Liver Disease. Drug Safety. 31(4). 325–334. 28 indexed citations

Paolini, John F., Yale Mitchel, Robert Reyes, et al.. (2007). Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix.. The American Journal of Cardiology. 101(5). 625–630. 128 indexed citations

10.

Morrison, Alan, Dena Rosen Ramey, Janet van Adelsberg, & Douglas J. Watson. (2007). Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension. Current Medical Research and Opinion. 23(10). 2395–2404. 46 indexed citations

11.

Bullano, Michael, Siddhesh Kamat, Vincent J. Willey, et al.. (2006). Agreement Between Administrative Claims and the Medical Record in Identifying Patients With a Diagnosis of Hypertension. Medical Care. 44(5). 486–490. 41 indexed citations

12.

Velentgas, Priscilla, William L. West, Carolyn C. Cannuscio, Douglas J. Watson, & Alexander M. Walker. (2006). Cardiovascular risk of selective cyclooxygenase‐2 inhibitors and other non‐aspirin non‐steroidal anti‐inflammatory medications. Pharmacoepidemiology and Drug Safety. 15(9). 641–652. 35 indexed citations

13.

Watson, Douglas J., et al.. (2005). The ASPA Journals: Who Is Publishing?. Journal of Public Affairs Education. 11(1). 53–60. 5 indexed citations

14.

Ramey, Dena Rosen, Douglas J. Watson, Chang Yu, et al.. (2005). The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis. Current Medical Research and Opinion. 21(5). 715–722. 59 indexed citations

15.

Watson, Douglas J., Thomas Rhodes, & Harry A. Guess. (2003). All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database.. PubMed. 30(6). 1196–202. 223 indexed citations

16.

Hunt, Richard H., S. E. Harper, Douglas J. Watson, et al.. (2003). The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. The American Journal of Gastroenterology. 98(8). 1725–1733. 122 indexed citations

17.

Schnitzer, Thomas J., Sheldon X. Kong, Panagiotis Mavros, et al.. (2003). An observational, retrospective, cohort study of dosing patterns for rofecoxib and celecoxib in the treatment of arthritis. Clinical Therapeutics. 25(12). 3162–3172. 7 indexed citations

18.

Watson, Douglas J., Thomas Rhodes, Bing Cai, & Harry A. Guess. (2002). Lower Risk of Thromboembolic Cardiovascular Events With Naproxen Among Patients With Rheumatoid Arthritis. Archives of Internal Medicine. 162(10). 1105–1105. 175 indexed citations

19.

Clearfield, Michael, Edwin J. Whitney, Stephen E. Weis, et al.. (2000). Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Baseline Characteristics and Comparison with USA Population. European Journal of Cardiovascular Prevention & Rehabilitation. 7(2). 125–133. 10 indexed citations

20.

Davies, Glenn, Douglas J. Watson, & Nicholas Bellamy. (1999). Comparison of the responsiveness and relative effect size of the Western Ontario and McMaster Universities Osteoarthritis Index and the Short-Form Medical Outcomes Study Survey in a randomized, clinical trial of osteoarthritis patients. Arthritis & Rheumatism. 12(3). 172–179. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact